Latest News Releases From The Newsroom
FTC Warns About Misuses of Biometric Information and Harm to Consumers
May 18th, 2023
Agency issues policy statement addressing emerging technologies that might harm consumers and violate the FTC Act Washington D.C. / CRWE PRESS RELEASE / May 18, 2023 - The Federal Trade Commission today issued a warning that the increasi. Read more
FTC Proposes Amendments to Strengthen and Modernize the Health Breach Notification Rule
May 18th, 2023
Proposed changes would underscore the rule’s applicability to health apps and other evolving technologies Washington D.C. / CRWE PRESS RELEASE / May 18, 2023 - The Federal Trade Commission is seeking comment on proposed changes to . Read more
Major Advancements in Biotech: Enveric Biosciences' Psilocin Prodrug Patent Allowance, Phio Pharma's Breakthrough in Cancer Therapy, and Teva's Strategic Framework
May 18th, 2023
Enveric Biosciences, Inc. (Nasdaq: ENVB) has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a patent application related to their new chemical entity (NCE) psilocin prodrug, known as EB-373. This prodrug. Read more
Monro Falls Short of Q4 Expectations as Micron Technology, Mullen Automotive, and FibroGen Make Positive Pre-Market Moves
May 18th, 2023
Monro, Inc. (Nasdaq: MNRO) has released its financial results for the fourth quarter of fiscal 2023, reporting adjusted earnings per share (EPS) that fell short of market expectations. The company's adjusted EPS for the quarter stood at $0.08, compar. Read more
Initiated with a Buy: Arcellx, Pliant Therapeutics, Tarsus Pharmaceuticals, Varonis Systems
May 18th, 2023
Several companies have recently received initiations with Buy ratings from prominent financial institutions, indicating positive outlooks for their future performance. Arcellx, Inc. (Nasdaq: ACLX) has been initiated with a Buy rating and a price t. Read more
EyePoint Pharma's YUTIQ Sale, Protalix's Milestone Achievement, and Walmart's Q1 Surpass Expectations: Pre-Market Update
May 18th, 2023
EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT) has announced a definitive agreement for the sale of YUTIQ, their fluocinolone acetonide intravitreal implant used in the treatment of chronic non-infectious uveitis affecting the posterior segment of the. Read more
Q1 2023 Earnings Report: KE Holdings and Bath & Body Works Exceed Expectations, Sociedad Química y Minera de Chile Falls Short; Revvity Inks Licensing Deal with AstraZeneca
May 18th, 2023
KE Holdings Inc. (NYSE: BEKE) reported better-than-expected adjusted earnings per share (EPS) for the first quarter of 2023. The company's adjusted EPS stood at $0.43, surpassing the consensus estimate of $0.23. In pre-market trading, $BEKE . Read more
BlackBerry Aims for Financial Growth, Take-Two Interactive Software Shines in Q4 Financial Report
May 17th, 2023
BlackBerry Limited (NYSE: BB) has unveiled its long-term financial targets, outlining its strategic objectives for the future. The company is aiming to achieve substantial improvements in non-GAAP EPS loss and cash flow utilization in FY24, . Read more
FTC to Host Workshop Examining Issues Related to Proposed Changes to the Funeral Rule
May 17th, 2023
Washington D.C. / CRWE PRESS RELEASE / May 17, 2023 - The Federal Trade Commission will hold a public workshop on September 7, 2023 seeking input on proposed changes to the Funeral Rule. The Commission issued an Advance Noti. Read more
National Western Life Group Exploring Strategic Alternatives, Bausch Health Surges on U.S. District Court's Decision, Kura Oncology Initiated with a Buy
May 17th, 2023
National Western Life Group, Inc. (Nasdaq: NWLI) has announced its intention to explore strategic alternatives with the aim of maximizing value for its stockholders. At this stage, no specific decision has been made regarding a sale, merger, or other. Read more
Want To Find Some News?
News By Industries
Recent Posts
-
Countdown to Earnings: Nutanix, CrowdStrike, and Synopsys on Deck
August 23rd, 2026Investors Eye Semtech, Intuit, and nCino as Earnings Loom
August 22nd, 2026FTC Files Amicus Brief to Protect Competition in Biologic Drug Markets
August 21st, 2026
Member Login